BBlogFlow

One Tech Tip: As Apple's Duo phone is released, here are dos and don'ts for folding phones - Yahoo! Finance Canada

·5h ago
Source: Yahoo! Finance Canada
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Yahoo! Finance Canada

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Bruce Poon Tip’s new book challenges traditional model of business leadership - Travelweek

TORONTO — G Adventures founder Bruce Poon Tip is challenging the traditional leadership model with a new book that explores how businesses can thrive beyond the influence of a single leader. Titled ‘Communityship: Lessons from the Universe and the Business of Everyone’, the book examines a leadership approach built on trust, shared responsibility, belonging and collective purpose. Published by HarperCollins in Canada and the U. S. on Nov. 24, 2026, it also features a foreword by the late Dr. Jane Goodall. The book is now available for pre-sale.

Travelweek·

Intravenous Thrombolysis Does Not Modify Endovascular Therapy for MDVO Strokes - HCPLive

News|Videos|October 22, 2026 Fabiano Cavalcante, MD, discusses his secondary analysis of the DISTAL trial, which revealed minimal association between IVT and the effect of EVT in MDVO strokes. Presented at the World Stroke Congress (WSC) 2026 in Seoul, South Korea, by Fabiano Cavalcante, MD, a PhD candidate at Amsterdam UMC and founder of Citadel Medical Sciences, these exploratory data may indicate that the threshold for procedural intervention in distal occlusions may be higher than previously believed.1“It’s very important that these results should be interpreted carefully,” Cavalcante told HCPLive in an exclusive interview. “I think they are more on the hypothesis-generating side than actually on the treatment decision side. We need more evidence from pooling these trials together to have a larger sample size or randomizing further patients, especially now that we know the results of the first 3 trials that didn’t show a clear benefit.”DISTAL was an open-label, randomized trial conducted across 56 locations worldwide.

HCPLive·